NeuroVive Pharmaceutical AB Owners

Health Care & Life Sciences » Pharmaceuticals | NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Andra AP-fonden

125,463

0.14%

125,463

12/31/2016

SEB Investment Management AB

54,708

0.06%

12/31/2017

Danske Bank A/S (Investment Management Sweden)

26,000

0.03%

09/11/2018

Catella Fondförvaltning AB

5,343

0.01%

08/31/2018

Xact Kapitalförvaltning AB

-419,103

08/31/2018

View Profile

Address	Medicon Village Lund SN 223 81 Sweden
Employees	-
Website	http://www.neurovive.com
Updated	07/08/2019
NeuroVive Pharmaceutical AB engages in the research and development of pharmaceuticals that protect mitochondria from death post acute traumatic injury. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden. .